{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T01:06:51Z","timestamp":1762909611723,"version":"3.45.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T00:00:00Z","timestamp":1729900800000},"content-version":"am","delay-in-days":360,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine and Research"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.resmer.2023.101050","type":"journal-article","created":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T11:35:21Z","timestamp":1695468921000},"page":"101050","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prognostic impact of venous thromboembolism on the course of sarcoidosis: A multicenter retrospective case-control study"],"prefix":"10.1016","volume":"84","author":[{"given":"Dov","family":"Taieb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Pastr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karine","family":"Juvin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Bouvry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4070-5569","authenticated-orcid":false,"given":"Florence","family":"Jeny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yurdag\u00fcl","family":"Uzunhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Valeyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilario","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Isra\u00ebl-Biet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.resmer.2023.101050_bib0001","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra071714","article-title":"Sarcoidosis","volume":"357","author":"Iannuzzi","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resmer.2023.101050_bib0002","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","volume":"383","author":"Valeyre","year":"2014","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.resmer.2023.101050_bib0003","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1183\/13993003.00457-2016","article-title":"Sarcoidosis-related mortality in France: a multiple-cause-of-death analysis","volume":"48","author":"Jamilloux","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resmer.2023.101050_bib0004","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01815-2017","article-title":"Sarcoidosis mortality in Sweden: a population-based cohort study","volume":"51","author":"Rossides","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resmer.2023.101050_bib0005","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.mayocp.2017.09.015","article-title":"Increased risk of multimorbidity in patients with sarcoidosis: a population-based cohort study 1976 to 2013","volume":"92","author":"Ungprasert","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.resmer.2023.101050_bib0006","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/thx.2010.134429","article-title":"Evidence for association between sarcoidosis and pulmonary embolism from 35-year record linkage study","volume":"66","author":"Crawshaw","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.resmer.2023.101050_bib0007","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1378\/chest.11-2514","article-title":"Increased number of pulmonary embolisms in sarcoidosis patients","volume":"141","author":"Vorselaars","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.resmer.2023.101050_bib0008","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1378\/chest.11-0324","article-title":"Increased risk of pulmonary embolism among US decedents with sarcoidosis from 1988 to 2007","volume":"140","author":"Swigris","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.resmer.2023.101050_bib0009","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00408-019-00210-x","article-title":"Inpatient prevalence, expenditures, and comorbidities of sarcoidosis: nationwide inpatient sample 2013-2014","volume":"197","author":"Ungprasert","year":"2019","journal-title":"Lung"},{"key":"10.1016\/j.resmer.2023.101050_bib0010","first-page":"170","article-title":"Sarcoidosis as a risk factor for venous thromboembolism","volume":"34","author":"Geremek","year":"2017","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis Off J WASOG"},{"key":"10.1016\/j.resmer.2023.101050_bib0011","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.chest.2016.09.009","article-title":"Association of sarcoidosis with increased risk of VTE: a population-based study, 1976 to 2013","volume":"151","author":"Ungprasert","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.resmer.2023.101050_bib0012","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.chest.2017.03.022","article-title":"Sarcoidosis and risk of VTE: validation with big data","volume":"151","author":"Yaqoob","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.resmer.2023.101050_bib0013","first-page":"e25520","article-title":"Association between sarcoidosis and risk of venous thromboembolism: a retrospective chart review","volume":"14","author":"Kassem","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.resmer.2023.101050_bib0014","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1164\/ajrccm.160.2.ats4-99","volume":"160","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resmer.2023.101050_bib0015","first-page":"19","article-title":"The WASOG Sarcoidosis Organ Assessment Instrument: an update of a previous clinical tool","volume":"31","author":"Judson","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis Off J WASOG"},{"key":"10.1016\/j.resmer.2023.101050_bib0016","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","article-title":"diagnosis and detection of sarcoidosis. An official American thoracic society clinical practice guideline","volume":"201","author":"Crouser","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resmer.2023.101050_bib0017","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S2213-2600(13)70276-5","article-title":"An integrated clinicoradiological staging system for pulmonary sarcoidosis: a case-cohort study","volume":"2","author":"Walsh","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.resmer.2023.101050_bib0018","doi-asserted-by":"crossref","first-page":"684","DOI":"10.7326\/0003-4819-156-10-201205150-00004","article-title":"A multidimensional index and staging system for idiopathic pulmonary fibrosis","volume":"156","author":"Ley","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.resmer.2023.101050_bib0019","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.ccm.2015.08.012","article-title":"Severe sarcoidosis","volume":"36","author":"Kouranos","year":"2015","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.resmer.2023.101050_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.105997","article-title":"Predictors of mortality in fibrosing pulmonary sarcoidosis","volume":"169","author":"Jeny","year":"2020","journal-title":"Respir Med"},{"key":"10.1016\/j.resmer.2023.101050_bib0021","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.athoracsur.2006.03.095","article-title":"The maximum standardized uptake values on integrated FDG-PET\/CT is useful in differentiating benign from malignant pulmonary nodules","volume":"82","author":"Bryant","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.resmer.2023.101050_bib0022","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1016\/j.rmr.2019.05.022","article-title":"groupe de travail Recommandations de bonne pratique pour la prise en charge de la MVTE. [What duration of anticoagulant treatment for PE\/proximal DVT?]","volume":"38","author":"Couturaud","year":"2021","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.resmer.2023.101050_bib0023","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1164\/rccm.200705-742OC","article-title":"Phenotyping sarcoidosis from a pulmonary perspective","volume":"177","author":"Prasse","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resmer.2023.101050_bib0024","first-page":"56","article-title":"Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force","volume":"28","author":"Baughman","year":"2011","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis Off J WASOG"},{"key":"10.1016\/j.resmer.2023.101050_bib0025","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2141.2005.05753.x","article-title":"The interactions between inflammation and coagulation","volume":"131","author":"Esmon","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.resmer.2023.101050_bib0026","first-page":"e23063","article-title":"The prevalence of pulmonary embolism in patients with interstitial lung disease: a cross-sectional retrospective study","volume":"14","author":"Alsilmi","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.resmer.2023.101050_bib0027","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0049-3848(00)00237-1","article-title":"Relevance of tissue factor and tissue factor pathway inhibitor for hypercoagulable state in the lungs of patients with idiopathic pulmonary fibrosis","volume":"99","author":"Fujii","year":"2000","journal-title":"Thromb Res"},{"key":"10.1016\/j.resmer.2023.101050_bib0028","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0049-3848(95)00025-9","article-title":"Increased procoagulant and antifibrinolytic activities in the lungs with idiopathic pulmonary fibrosis","volume":"77","author":"Kotani","year":"1995","journal-title":"Thromb Res"},{"key":"10.1016\/j.resmer.2023.101050_bib0029","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.semarthrit.2010.10.002","article-title":"Coagulation and autoimmunity in scleroderma interstitial lung disease","volume":"41","author":"Ludwicka-Bradley","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.resmer.2023.101050_bib0030","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/35025229","article-title":"Thrombin signalling and protease-activated receptors","volume":"407","author":"Coughlin","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.resmer.2023.101050_bib0031","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1165\/ajrcmb.10.4.7510986","article-title":"Scleroderma bronchoalveolar lavage fluid contains thrombin, a mediator of human lung fibroblast proliferation via induction of platelet-derived growth factor alpha-receptor","volume":"10","author":"Ohba","year":"1994","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.resmer.2023.101050_bib0032","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0140-6736(95)91744-6","article-title":"Role of thrombin in pulmonary fibrosis","volume":"346","author":"Hern\u00e1ndez-Rodr\u00edguez","year":"1995","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.resmer.2023.101050_bib0033","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1378\/chest.117.4.1012","article-title":"Circulating D dimer in patients with sarcoidosis","volume":"117","author":"Shorr","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.resmer.2023.101050_bib0034","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1378\/chest.103.4.1100","article-title":"Elevated D dimer in the lungs and blood of patients with sarcoidosis","volume":"103","author":"Perez","year":"1993","journal-title":"Chest"},{"key":"10.1016\/j.resmer.2023.101050_bib0035","first-page":"297","article-title":"Bronchoalveolar lavage fluid D dimer levels are higher and more prevalent in black patients with pulmonary sarcoidosis","volume":"74","author":"Perez","year":"2007","journal-title":"Respir Int Rev Thorac Dis"},{"key":"10.1016\/j.resmer.2023.101050_bib0036","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jamainternmed.2013.122","article-title":"Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study","volume":"173","author":"Johannesdottir","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.resmer.2023.101050_bib0037","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.amjcard.2021.03.017","article-title":"Effect of corticosteroid therapy in patients with cardiac sarcoidosis on frequency of venous thromboembolism","volume":"149","author":"Kolluri","year":"2021","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.resmer.2023.101050_bib0038","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1055\/s-0036-1579642","article-title":"Thrombosis in autoimmune diseases: a role for immunosuppressive treatments?","volume":"42","author":"Silvestri","year":"2016","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.resmer.2023.101050_bib0039","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1378\/chest.105.4.1179","article-title":"Antiphospholipid antibodies. A prognostic factor in sarcoidosis?","volume":"105","author":"Ina","year":"1994","journal-title":"Chest"},{"key":"10.1016\/j.resmer.2023.101050_bib0040","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1440-1843.2006.00880.x","article-title":"Pulmonary sarcoidosis and antiphospholipid syndrome","volume":"11","author":"Takahashi","year":"2006","journal-title":"Respirol Carlton Vic"},{"key":"10.1016\/j.resmer.2023.101050_bib0041","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.3390\/jcm10112462","article-title":"Correlation between potential risk factors and pulmonary embolism in sarcoidosis patients timely treated","volume":"10","author":"Ruaro","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.resmer.2023.101050_bib0042","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/thx.34.1.127","article-title":"Myocardial sarcoidosis complicated by mural thrombosis","volume":"34","author":"Wynne","year":"1979","journal-title":"Thorax"},{"key":"10.1016\/j.resmer.2023.101050_bib0043","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1259\/0007-1285-56-670-755","article-title":"Meningeal sarcoidosis causing intracranial hypertension secondary to dural sinus thrombosis","volume":"56","author":"Byrne","year":"1983","journal-title":"Br J Radiol"},{"key":"10.1016\/j.resmer.2023.101050_bib0044","first-page":"188","article-title":"Pseudotumor cerebri secondary to dural sinus thrombosis in neurosarcoidosis","volume":"13","author":"Akova","year":"1993","journal-title":"J Clin Neuroophthalmol"},{"key":"10.1016\/j.resmer.2023.101050_bib0045","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/hep.510260304","article-title":"The role of granulomatous phlebitis and thrombosis in the pathogenesis of cirrhosis and portal hypertension in sarcoidosis","volume":"26","author":"Moreno-Merlo","year":"1997","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.resmer.2023.101050_bib0046","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1136\/thorax.58.6.552-a","article-title":"Sarcoidosis presenting as upper extremity venous thrombosis","volume":"58","author":"McLaughlin","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.resmer.2023.101050_bib0047","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0761-8425(08)70477-7","article-title":"[Thoracic venous thrombosis in the course of sarcoidosis]","volume":"25","author":"Marc","year":"2008","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.resmer.2023.101050_bib0048","doi-asserted-by":"crossref","first-page":"723","DOI":"10.2169\/internalmedicine.48.1809","article-title":"Cerebral venous thrombosis in a patient with sarcoidosis","volume":"48","author":"Selvi","year":"2009","journal-title":"Intern Med Tokyo Jpn"},{"key":"10.1016\/j.resmer.2023.101050_bib0049","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/MCP.0000000000000604","article-title":"Indications for treatment of sarcoidosis","volume":"25","author":"Nunes","year":"2019","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.resmer.2023.101050_bib0050","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04079-2020","article-title":"ERS clinical practice guidelines on treatment of sarcoidosis","author":"Baughman","year":"2021","journal-title":"Eur Respir J"}],"container-title":["Respiratory Medicine and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590041223000624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590041223000624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T01:04:21Z","timestamp":1762909461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590041223000624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":50,"alternative-id":["S2590041223000624"],"URL":"https:\/\/doi.org\/10.1016\/j.resmer.2023.101050","relation":{},"ISSN":["2590-0412"],"issn-type":[{"type":"print","value":"2590-0412"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic impact of venous thromboembolism on the course of sarcoidosis: A multicenter retrospective case-control study","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine and Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resmer.2023.101050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 SPLF and Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101050"}}